{"id":"W3134204216","doi":"10.1016/j.thromres.2021.03.004","title":"5-year outcomes from rivaroxaban therapy in atrial fibrillation: Results from the Dresden NOAC Registry","year":2021,"lang":"en","type":"article","venue":"Thrombosis Research","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Pfizer Canada; Boehringer Ingelheim; Daiichi Sankyo Company; Bayer","keywords":"Rivaroxaban; Medicine; Discontinuation; Atrial fibrillation; Warfarin; Stroke (engine); Cohort; Hazard ratio; Confidence interval; Randomized controlled trial; Internal medicine; Cohort study; Clinical endpoint; Surgery","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001505114,0.0002088528,0.0005687308,0.0001541346,0.0002648034,0.0001886341,0.0003333639,0.0001979215,0.001858943],"category_scores_gemma":[0.00283787,0.0001447652,0.0003623389,0.001008454,0.0001947199,0.0001570132,0.0003268033,0.0005467324,0.0004352613],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001559288,"about_ca_system_score_gemma":0.0002744009,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003506467,"about_ca_topic_score_gemma":0.0004659901,"domain_scores_codex":[0.9960518,0.0007534777,0.000637926,0.0006382894,0.001433463,0.0004849772],"domain_scores_gemma":[0.994211,0.003965272,0.0001150157,0.001275626,0.0003031846,0.0001299357],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001137525,0.00001327378,0.975844,0.000006944356,0.0004001756,0.00003793182,0.001197114,0.00004992053,0.001951593,0.0005974552,0.01333637,0.005427644],"study_design_scores_gemma":[0.006591318,0.00008287767,0.9377016,0.00007883809,0.00003890882,4.994357e-7,0.001160268,0.0001290514,0.001066344,0.001910607,0.05108589,0.0001537295],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9281803,0.0009267828,0.000007474119,0.06128408,0.0003960913,0.0007361256,0.0001607983,0.00007078663,0.008237577],"genre_scores_gemma":[0.9886728,0.00217952,0.000541306,0.0002835422,0.003882454,0.000003129049,0.0006555043,0.00004032462,0.003741454],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06100054,"threshold_uncertainty_score":0.9990535,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.281032344180189,"score_gpt":0.4503697496969611,"score_spread":0.1693374055167722,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}